Levofloxacin-Ketoprofen Multicomponent Salt Development as A Strategy to Improve the Antibiotic Potency and Anti-Inflammatory Performance
Makara Journal of Science · 28.09.2026 · 30 (3)
DOI: 10.7454/mss.v30i3.3276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Makara Journal of Science, online erschienen am 28.09.2026. Verfasst von Ilma Nugrahani.
Abstract (Originalsprache)
Levofloxacin is a fluoroquinolone antibiotic with higher solubility than those from previous generations, but it is light-sensitive. Antibiotics, including levofloxacin, are generally prescribed in combination with nonsteroidal anti-inflamma-tory drugs (NSAIDs) to treat inflammatory infections. Furthermore, NSAIDs have poor water solubility, which can be improved by forming salts or multicomponent systems. This study aimed to develop a multicomponent system from levofloxacin with ketoprofen, an NSAID, and to evaluate its physicochemical characteristics; antibiotic potency; in vivo anti-inflammatory activity; absorption, distribution, metabolism, and excretion (ADME); and in silico toxicity risk. First, a phase diagram was created to predict the interaction type in the resulting multicomponent system and determine the appropriate stoichiometric molar ratio. Next, the multicomponent system was prepared by solvent-drop grinding and analyzed using thermal analysis and powder X-ray diffractometry. The next stage involved structure determination, per-formed using Fourier transform infrared and nuclear magnetic resonance, which revealed the formation of a multicom-ponent salt. The salt was further shown to increase the stability of levofloxacin and the solubility of ketoprofen, thereby increasing antibiotic potency against gram-positive (Staphylococcus aureus) and gram-negative (Escherichia coli) bacte-ria, as well as inducing anti-inflammatory activity in Wistar rats. Complementing this study, in silico tests were conducted using SwissADME and ProTox 3.0, yielding data indicating that the formation of the levofloxacin-ketoprofen salt may reduce the risk of nerve, kidney, and respiratory toxicity, as well as mutagenic toxicity, and may lower blood-brain barrier penetration. Thus, the levofloxacin-ketoprofen salt has the potential to be further developed into various formulations and would require additional testing, including in vivo toxicity studies and clinical trials.
Zitieren
APA
Nugrahani, I. (2026). Levofloxacin-Ketoprofen Multicomponent Salt Development as A Strategy to Improve the Antibiotic Potency and Anti-Inflammatory Performance. Makara Journal of Science, 30(3). https://doi.org/10.7454/mss.v30i3.3276
Vancouver
Nugrahani I. Levofloxacin-Ketoprofen Multicomponent Salt Development as A Strategy to Improve the Antibiotic Potency and Anti-Inflammatory Performance. Makara Journal of Science. 2026;30(3). doi:10.7454/mss.v30i3.3276
BibTeX
@article{Nugrahani2026,
author = {Nugrahani, Ilma},
title = {Levofloxacin-Ketoprofen Multicomponent Salt Development as A Strategy to Improve the Antibiotic Potency and Anti-Inflammatory Performance},
journal = {Makara Journal of Science},
year = {2026},
volume = {30},
number = {3},
doi = {10.7454/mss.v30i3.3276}
}
EUVIMED